Von Rickenbach Josef H
VON RICKENBACH JOSEF H, DIR, reported an open-market or private purchase at Rein Therapeutics, Inc. involving 15950.000000 shares for an estimated $16707.63. Reported holdings after the transaction were 34824.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- May 22, 2026
- Filing date
- May 29, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 18,874 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingRNTX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001193125-26-245832 Common stock , $0.001 par value
- Transaction date
- May 22, 2026 Filed May 29, 2026, 12:15 AM · 7d delay
- Shares
- 15,950 sh $1.05 per share
- Estimated value
- $16.7k Computed from shares × price
- Holdings after
- 34,824 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+26 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - director_buy+6 points
is_director = true
Director open-market purchase. - large_holdings_increase+8 points
large-holdings-increase signal matched
Reported acquired shares meet the configured percentage of post-transaction holdings. - delayed_filing-6 points
reporting_delay_days = 7
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026…
0 other transactions
0 recent txs